Medicare Enrolled
Dr. Amparo Gordian, MD
Rheumatology · Bradenton, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gordian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gordian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gordian
Dr. Amparo Gordian is a rheumatology specialist in Bradenton, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gordian performed 262,391 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gordian received a total of $9,790 from 39 pharmaceutical and/or device companies across 501 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gordian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 4% volume in FL
$9,790 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 149438 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗262,391
Medicare services
Top 4% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
90,800 | $4 | $20 |
| Tocilizumab injection (Actemra) | 58,731 | $5 | $10 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
52,294 | $10 | $50 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
32,701 | $34 | $100 |
| Denosumab injection (Prolia/Xgeva) | 7,921 | $18 | $28 |
| Romosozumab injection (Evenity) for osteoporosis | 5,040 | $8 | $12 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
4,908 | $64 | $175 |
| Belimumab injection, 10 mg An injection of belimumab, a medication administered at a dose of 10 mg. |
3,712 | $40 | $83 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
3,170 | $26 | $110 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
752 | $48 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
734 | $87 | $289 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
617 | $11 | $30 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
305 | $98 | $550 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
155 | $21 | $150 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
140 | $6 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
122 | $116 | $350 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
72 | $12 | $34 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
63 | $4 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $136 | $282 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
38 | $55 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $65 | $200 |
| New patient office visit, complex (60-74 min) | 33 | $160 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
34.0% high complexity
65.6% medium
0.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,790
Total received (2018-2024)
Avg $1,399/year across 7 years
Top 43% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
501
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,917
2023
$2,952
2022
$2,285
2021
$351
2020
$78
2019
$593
2018
$614
Payments by company (2024)
Janssen Biotech, Inc.
$558
Novartis Pharmaceuticals Corporation
$511
Amgen Inc.
$348
Lilly USA, LLC
$239
ABBVIE INC.
$231
UCB, Inc.
$226
E.R. Squibb & Sons, L.L.C.
$144
PFIZER INC.
$120
Fresenius Kabi USA, LLC
$106
GlaxoSmithKline, LLC.
$89
AstraZeneca Pharmaceuticals LP
$81
Aurinia Pharma U.S., Inc.
$59
Organon Llc
$59
Kiniksa Pharmaceuticals International, plc
$37
Genentech USA, Inc.
$33
Janssen Scientific Affairs, LLC
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Mallinckrodt Hospital Products Inc.
$20
Top 3 companies account for 48.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,633
Novartis Pharmaceuticals Corporation
$1,255
Amgen Inc.
$926
UCB, Inc.
$760
ABBVIE INC.
$704
PFIZER INC.
$697
GlaxoSmithKline, LLC.
$595
Lilly USA, LLC
$565
AstraZeneca Pharmaceuticals LP
$482
Aurinia Pharma U.S., Inc.
$417
E.R. Squibb & Sons, L.L.C.
$287
Horizon Therapeutics plc
$244
Fresenius Kabi USA, LLC
$157
Regeneron Healthcare Solutions, Inc.
$137
Radius Health, Inc.
$110
Boehringer Ingelheim Pharmaceuticals, Inc.
$104
Takeda Pharmaceuticals U.S.A., Inc.
$88
AbbVie Inc.
$83
Janssen Scientific Affairs, LLC
$62
Celgene Corporation
$59
Organon Llc
$59
Kiniksa Pharmaceuticals International, plc
$37
Genentech USA, Inc.
$33
GENZYME CORPORATION
$30
Merck Sharp & Dohme Corporation
$27
Mylan Institutional Inc.
$25
Nabriva Therapeutics, plc
$23
TerSera Therapeutics LLC
$21
Mallinckrodt Hospital Products Inc.
$20
Exeltis, USA Inc.
$19
Novo Nordisk Inc
$19
Sandoz Inc.
$19
Pacira Pharmaceuticals Incorporated
$17
Sobi, Inc
$17
Actelion Pharmaceuticals US, Inc.
$16
SANOFI PASTEUR INC.
$12
Teva Pharmaceuticals USA, Inc.
$11
West-Ward Pharmaceuticals
$11
Sebela Pharmaceuticals Inc.
$11
Top 3 companies account for 39.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMJEVITA · Actemra · Aimovig · Arcalyst · BENLYSTA · BEVESPI AEROSPHERE · Bimzelx · CHANTIX · COLOGUARD · COSENTYX · CYLTEZO · Cimzia · ENTRESTO · EVENITY · EVUSHELD · Enbrel · FLUZONE QUADRIVALENT · HUMIRA · HYRIMOZ · IDACIO · ILARIS · INFLECTRA · Iovera · JANUVIA · JARDIANCE · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · LUPKYNIS · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · Otezla · PNEUMOVAX 23 · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPEVIGO · SYMBICORT · Saxenda · TALTZ · TAVNEOS · TREMFYA · TRULICITY · Trintellix · Tymlos · XELJANZ · Xenleta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
35
County median income
$75,792
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA BLAKE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gordian is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gordian experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Gordian performed 90,800 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gordian receive payments from pharmaceutical companies?
Yes. Dr. Gordian received a total of $9,790 from 39 companies across 501 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gordian's costs compare to other rheumatologists in Bradenton?
Dr. Gordian's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gordian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Bradenton
Browse rheumatologists in Bradenton ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology